| 摘要 |
The present invention relates to compounds of general formula (I), wherein R1, Lp, HetAr, Ar, and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity. |
| 申请人 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH;NEUROCRINE BIOSCIENCES, INC.;HECKEL, ARMIN;HIMMELSBACH, FRANK;LANGKOPF, ELKE;NOSSE, BERND;ASHWEEK, NEIL, J.;HARRIOTT, NICOLE |
发明人 |
HECKEL, ARMIN;HIMMELSBACH, FRANK;LANGKOPF, ELKE;NOSSE, BERND;ASHWEEK, NEIL, J.;HARRIOTT, NICOLE |
